You are here: HomeNews → News Story

BDI SUCCESS AT INVENT COMMERCIALISATION AWARDS 2015

04.15



These awards were established by DCU Invent to publicly recognise researchers who work with Invent to protect and commercialise their research. Three categories are recognised: licence options; licences to existing companies and licences to spin-outs.

The BDI projects that received awards this year are;

BBI / DiCAST - innovative platform that offers a novel approach to discovery of monoclonal antibodies for therapeutic and diagnostic use. The team received this award for their licence option to BBI solutions. Congratulations to the winning team lead by Dr. Paul Leonard - Mr. Brian Manning, Ms. Valerie Fitzgerald, Dr. Ruth Laraghy and Mr. Barry O'Donnell.

Randox - focusing on biochip array assay for the detection of colorectal cancer antibodies. The research team received the award for an Innovation Partnership with Randox Teoranta. Congratulations to the full team led by Prof. Richard O'Kennedy - Prof. Dermot Kenny, Prof. Elaine Kay, Dr. Elaine Harris, Dr. Barry Byrne, Dr. Gregor Kijanka, Mr. Kieran Flynn, Dr. Julie-Ann O'Reilly, Dr. Conor Burke and Mr. Sean Fitzgerald.

Inform Biosciences - focusing on the validation and development of a preeclampsia risk stratification technology into a near-patient product. The research team received this award for an Innovation Partnership between Inform Biosciences, BDI and Mayo Clinic. Congratulations to the full team - Prof. Christine Loscher, Prof. Richard O'Kennedy, Dr. Barry Byrne, Dr Maja Kristek.

Bluebridge - focusing on real time pH Sensors for Clinical Applications. The research team received this award for an Innovation Partnership and Licence with Bluebridge Technologies. Congratulations to the full team - Dr. Dorota Wencel, Ms. Denise Carthy, Prof. Colette McDonagh, Mr. Kieran Flynn and Dr. Conor Burke.